131 related articles for article (PubMed ID: 38530792)
1. Retraction: Fumagillin regulates stemness and malignancies in cancer stem-like cells derived from liver cancer via targeting to MetAP-2.
PLOS ONE Editors
PLoS One; 2024; 19(3):e0300802. PubMed ID: 38530792
[No Abstract] [Full Text] [Related]
2. Fumagillin regulates stemness and malignancies in cancer stem-like cells derived from liver cancer via targeting to MetAP-2.
Zhang K; Hu J; Zhao Z
PLoS One; 2023; 18(7):e0289024. PubMed ID: 37506053
[TBL] [Abstract][Full Text] [Related]
3. Understanding the selectivity of fumagillin for the methionine aminopeptidase type II.
Klein CD; Folkers G
Oncol Res; 2003; 13(12):513-20. PubMed ID: 12899241
[TBL] [Abstract][Full Text] [Related]
4. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2.
Sin N; Meng L; Wang MQ; Wen JJ; Bornmann WG; Crews CM
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6099-103. PubMed ID: 9177176
[TBL] [Abstract][Full Text] [Related]
5. Structure of human methionine aminopeptidase-2 complexed with fumagillin.
Liu S; Widom J; Kemp CW; Crews CM; Clardy J
Science; 1998 Nov; 282(5392):1324-7. PubMed ID: 9812898
[TBL] [Abstract][Full Text] [Related]
6. The development of MetAP-2 inhibitors in cancer treatment.
Yin SQ; Wang JJ; Zhang CM; Liu ZP
Curr Med Chem; 2012; 19(7):1021-35. PubMed ID: 22229417
[TBL] [Abstract][Full Text] [Related]
7. Methionine aminopeptidases type I and type II are essential to control cell proliferation.
Bernier SG; Taghizadeh N; Thompson CD; Westlin WF; Hannig G
J Cell Biochem; 2005 Aug; 95(6):1191-203. PubMed ID: 15962312
[TBL] [Abstract][Full Text] [Related]
8. Fumagillin treatment of hepatocellular carcinoma in rats: an in vivo study of antiangiogenesis.
Sheen IS; Jeng KS; Jeng WJ; Jeng CJ; Wang YC; Gu SL; Tseng SY; Chu CM; Lin CH; Chang KM
World J Gastroenterol; 2005 Feb; 11(6):771-7. PubMed ID: 15682466
[TBL] [Abstract][Full Text] [Related]
9. Methionine AminoPeptidase Type-2 Inhibitors Targeting Angiogenesis.
Ehlers T; Furness S; Robinson TP; Zhong HA; Goldsmith D; Aribser J; Bowen JP
Curr Top Med Chem; 2016; 16(13):1478-88. PubMed ID: 26369821
[TBL] [Abstract][Full Text] [Related]
10. A novel methionine aminopeptidase-2 inhibitor, PPI-2458, inhibits non-Hodgkin's lymphoma cell proliferation in vitro and in vivo.
Cooper AC; Karp RM; Clark EJ; Taghizadeh NR; Hoyt JG; Labenski MT; Murray MJ; Hannig G; Westlin WF; Thompson CD
Clin Cancer Res; 2006 Apr; 12(8):2583-90. PubMed ID: 16638869
[TBL] [Abstract][Full Text] [Related]
11. MetAP-2 inhibitors based on the fumagillin structure. Side-chain modification and ring-substituted analogues.
Rodeschini V; Boiteau JG; Van de Weghe P; Tarnus C; Eustache J
J Org Chem; 2004 Jan; 69(2):357-73. PubMed ID: 14725448
[TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibitors of methionine aminopeptidase type 2 (MetAP-2).
Garrabrant T; Tuman RW; Ludovici D; Tominovich R; Simoneaux RL; Galemmo RA; Johnson DL
Angiogenesis; 2004; 7(2):91-6. PubMed ID: 15516829
[TBL] [Abstract][Full Text] [Related]
13. Methionine aminopeptidases as potential targets for treatment of gastrointestinal cancers and other tumours.
Mauriz JL; Martín-Renedo J; García-Palomo A; Tuñón MJ; González-Gallego J
Curr Drug Targets; 2010 Nov; 11(11):1439-57. PubMed ID: 20583970
[TBL] [Abstract][Full Text] [Related]
14. Phylogenetic relationships of methionine aminopeptidase 2 among Encephalitozoon species and genotypes of microsporidia.
Pandrea I; Mittleider D; Brindley PJ; Didier ES; Robertson DL
Mol Biochem Parasitol; 2005 Apr; 140(2):141-52. PubMed ID: 15760654
[TBL] [Abstract][Full Text] [Related]
15. Spiroepoxytriazoles Are Fumagillin-like Irreversible Inhibitors of MetAP2 with Potent Cellular Activity.
Morgen M; Jöst C; Malz M; Janowski R; Niessing D; Klein CD; Gunkel N; Miller AK
ACS Chem Biol; 2016 Apr; 11(4):1001-11. PubMed ID: 26686773
[TBL] [Abstract][Full Text] [Related]
16. A single amino acid residue defines the difference in ovalicin sensitivity between type I and II methionine aminopeptidases.
Brdlik CM; Crews CM
J Biol Chem; 2004 Mar; 279(10):9475-80. PubMed ID: 14676204
[TBL] [Abstract][Full Text] [Related]
17. Investigation of novel fumagillin analogues as angiogenesis inhibitors.
Pyun HJ; Fardis M; Tario J; Yang CY; Ruckman J; Henninger D; Jin H; Kim CU
Bioorg Med Chem Lett; 2004 Jan; 14(1):91-4. PubMed ID: 14684305
[TBL] [Abstract][Full Text] [Related]
18. Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest.
Yeh JJ; Ju R; Brdlik CM; Zhang W; Zhang Y; Matyskiela ME; Shotwell JD; Crews CM
Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10379-10384. PubMed ID: 16790550
[TBL] [Abstract][Full Text] [Related]
19. Novel reversible methionine aminopeptidase-2 (MetAP-2) inhibitors based on purine and related bicyclic templates.
Heinrich T; Buchstaller HP; Cezanne B; Rohdich F; Bomke J; Friese-Hamim M; Krier M; Knöchel T; Musil D; Leuthner B; Zenke F
Bioorg Med Chem Lett; 2017 Feb; 27(3):551-556. PubMed ID: 27998678
[TBL] [Abstract][Full Text] [Related]
20. Compensatory cross-talk between autophagy and glycolysis regulates senescence and stemness in heterogeneous glioblastoma tumor subpopulations.
Martell E; Kuzmychova H; Senthil H; Kaul E; Chokshi CR; Venugopal C; Anderson CM; Singh SK; Sharif T
Acta Neuropathol Commun; 2023 Jul; 11(1):110. PubMed ID: 37420311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
